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Abstract
The sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) plays a critical role in Ca2+ homeostasis
via sequestration of this ion into the sarco/endoplasmic reticulum. The activity of this pump is
inhibited by oxidants and impaired in ageing tissues and cardiovascular disease. We have shown
previously that the myeloperoxidase- (MPO) derived oxidants HOCl and HOSCN target thiols and
mediate cellular dysfunction. As SERCA contains Cys residues critical to ATPase activity, we
hypothesized that HOCl and HOSCN might inhibit SERCA activity, via thiol oxidation, and
increase cytosolic Ca2+ levels in human coronary artery endothelial cells (HCAEC). Exposure of
sarcoplasmic reticulum vesicles to pre-formed or enzymatically-generated HOCl and HOSCN
resulted in a concentration-dependent decrease in ATPase activity; this was also inhibited by the
SERCA inhibitor thapsigargin. Decomposed HOSCN and incomplete MPO enzyme systems did
not decrease activity. Loss of ATPase activity occurred concurrently with oxidation of SERCA
Cys residues and protein modification. Exposure of HCAEC, with or without external Ca2+, to
HOSCN or HOCl, resulted in a time- and concentration-dependent increase in intracellular Ca2+
under conditions that did not result in immediate loss of cell viability. Thapsigargin, but not
inhibitors of plasma membrane or mitochondrial Ca2+ pumps/channels, completely attenuated the
increase in intracellular Ca2+ consistent with a critical role for SERCA in maintaining endothelial
cell Ca2+ homeostasis. Angiotensin II pre-treatment potentiated the effect of HOSCN at low
concentrations. MPO-mediated modulation of intracellular Ca2+ levels may exacerbate endothelial
dysfunction, a key early event in atherosclerosis, and be more marked in smokers due to their
higher SCN− levels.
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Introduction
Considerable evidence has been presented in support of the hypothesis that the level of the
heme enzyme myeloperoxidase (MPO), is an important risk factor for multiple
inflammatory diseases including atherosclerosis, neurodegenerative conditions and some
cancers (reviewed in [1-3]). This enzyme has also been linked with other human pathologies
including arthritis, asthma, cystic fibrosis and kidney damage. Circulating levels of MPO
have been shown to be a major risk factor for coronary artery disease, with a higher odds
ratio than total cholesterol (as a ratio with high-density lipoprotein cholesterol; odds ratios of
20.4 and 4.2, respectively) in multivariable models after adjustment for other factors [4].
MPO levels can also predict health outcomes in people presenting with chest pain [5], in
patients with acute coronary syndromes [6], and in patients that have suffered a myocardial
infarction [7]. However, the MPO-derived species and mechanisms responsible for this
elevated disease risk, and detrimental patient outcomes, remain unknown.
MPO is released by activated neutrophils, monocytes and tissue macrophages at sites of
inflammation, including within atherosclerotic lesions. MPO catalyzes the reaction of
hydrogen peroxide (H2O2) with halide and pseudohalide ions (Cl−, Br−, I− and SCN−) to
form hypohalous acids (hypochlorous acid, HOCl, from Cl−; hypobromous acid, HOBr,
from Br− and hypothiocyanous acid, HOSCN, from SCN−); these species are potent
oxidants [1,2,8]. HOCl and HOSCN are the major oxidants formed by MPO with normal
plasma levels of halides and SCN− (100 mM Cl−, ∼100 μM Br−, < 1 μM I−, ∼ 50 μM
SCN−), as SCN− has a very high specificity constant for MPO [9]. The concentration of
these oxidants formed at inflammatory sites has been estimated (using a blood concentration
of neutrophils of ∼ 5 × 106 cells mL−1) as 250-425 μmoles of HOCl per hour [10,11].
These MPO-derived oxidants play a major role in killing bacteria and other invading
pathogens [2,8,12,13], but excessive or misplaced generation can result in damage to both
host cells (including the endothelium of the artery wall) and extracellular components.
Enzymatically-active MPO protein has been shown to be present throughout the intima in all
grades of human atherosclerotic lesions, and is present at particularly high levels in shoulder
regions where lesion rupture is often detected [14]. The thickening of the intima in human
lesions correlates with the extent of staining by a monoclonal antibody specific for HOCl-
damaged proteins [15,16], and markedly elevated levels of the HOCl biomarkers, 3-chloro-
tyrosine and 5-chloro-uracil, have been detected in human atherosclerotic lesions [17,18]. In
contrast, the role of HOSCN in disease is less well established. It has been shown that the
amount of oxidized low-density lipoproteins (LDL) present in fatty streaks in the aortae of
young people correlates with serum SCN- levels [19]. Furthermore smokers, who have high
SCN- levels, have larger numbers of lipid-laden macrophages than non-smokers [20].
Unlike HOCl, which has been shown to react with a wide range of biological targets (though
primarily proteins) [21-23], HOSCN reacts with great specificity with thiols (both
glutathione (GSH) and protein cysteine (Cys) residues) and selenium-containing species
[24,25]. There are therefore very major differences in the reactivity of these two oxidants
and they would be expected to have different biological effects; recent studies support this
conclusion [26,27]. The selectivity of HOSCN for thiols can result in significant and specific
damage to cellular enzymes that contain active site Cys residues [26-28], elicits significantly
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greater cellular dysfunction than identical concentrations of HOCl and HOBr, with this
linked to protein thiol oxidation [27], and increases the extent of thiol oxidation in plasma
from smokers compared to non-smokers [29].
The sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) plays a critical role in regulating
calcium homeostasis by transporting cytosolic Ca2+ into the sarco/endoplasmic reticulum,
thus lowering intracellular Ca2+ levels. Through this process of Ca2+ sequestration, SERCA
mediates smooth, cardiac and skeletal muscle cell relaxation, and also participates in a
variety of cellular functions relevant to growth, proliferation and apoptosis [30,31]. At least
ten isoforms of SERCA have been detected in mammalian tissues, encoded by three distinct
genes: SERCA1, 2 and 3. SERCA1 is expressed in fast-twitch skeletal muscle and is
alternatively spliced to give the adult (SERCA1a) and neonatal (SERCA1b) forms. SERCA2
encodes the cardiac and slow-twitch muscle isoform, SERCA2a, as well as the ubiquitously
expressed SERCA2b. SERCA3 is expressed in a variety of tissues including non-muscle
cells and has 6 isoforms, designated SERCA3a-f [32].
SERCA activity can be modulated by reversible nitric oxide (NO.)-dependent S-
glutathiolation of specific Cys residues [33], a process that is impaired in ageing tissues [34]
and cardiovascular disease [33]. In pathophysiological states such as atherosclerosis, where
reactive species are generated in excess, critical SERCA thiols can become irreversibly
oxidized, leading to a loss of enzyme function [35]. Consistent with these data, peroxynitrite
[36], NO. and NO.-derived species [37] and amino acid peroxides [38] have been shown to
inhibit Ca2+-ATPase activity by selectively targeting SERCA Cys residues. In the light of
these data, the present study has investigated whether HOCl and HOSCN, at
pathophysiologically-relevant concentrations, can modify partially-purified SERCA
(possibly via targeting of cysteine residues), thereby inhibiting Ca2+-ATPase activity, and
whether the reactivity of these oxidants differ as might be expected. These studies have
subsequently been extended to examine whether these MPO-derived oxidants can perturb
Ca2+ homeostasis in human coronary artery endothelial cells (HCAEC) through a SERCA-
dependent mechanism. Such modifications may generate or exacerbate endothelial
dysfunction, a key early event in atherosclerosis.
Materials and Methods
Materials
Aqueous solutions and buffers were prepared using nanopure water filtered through a four-
stage Milli-Q system (Millipore, North Ryde, Australia). Lactoperoxidase (LPO, from
bovine milk; Calbiochem) was quantified by absorbance at 412 nm using a molar absorption
coefficient of 112,000 M−1 cm−1[39]. H2O2 (30 % v/v, Merck) was quantified by
absorbance at 240 nm using a molar absorption coefficient of 39.4 M−1 cm−1 [40]. ThioGlo1
was obtained from Calbiochem. Fura-2AM and 5-iodoacetamidofluoroescein (IAF) were
from Molecular Probes (Life Technologies). NaOCl and tri-sodium citrate were from BDH
(Poole, UK). Acetonitrile and HCl (HPLC grade) were from Merck. Tris-glycine 4-15 %
gradient gels and Precision Plus Kaleidoscope standards were from Bio-Rad. Ammonium
molybdate was from M & B. NaCl and PBS were from Amresco. MesoEndo Growth
Medium and HCAEC were purchased from Cell Applications. Molecular mass cut-off
devices were from Nanosep (Pall Life Sciences). All other chemicals were obtained from
Sigma-Aldrich.
Isolation of sarcoplasmic reticulum (SR) vesicles
Native SR vesicles were isolated from 6-month old Fisher 344 × Brown Norway F1 hybrid
rat hind-limb skeletal muscles (fast-twitch fibers), as previously described [38].
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Incubation of SR vesicles with HOSCN and HOCl
HOSCN was prepared enzymatically using bovine milk LPO, as previously described
[27,41]. Briefly, 1.5-2.0 μM LPO was incubated with 7.5 mM NaSCN and 3.75 mM H2O2
(added in 5 aliquots, 60 s apart) for 15 min in 8.5 mM potassium phosphate buffer, pH 6.6.
The reaction was stopped by the addition of catalase (bovine liver, 140 IU), which was
removed along with the LPO by centrifugation (5 min, 11,200 g) through 10 kDa molecular
mass cut-off filters. The concentration of HOSCN was immediately determined by reaction
with TNB (5-thio-2-nitrobenzoic acid; prepared by alkaline hydrolysis of DTNB with
NaOH), using a molar absorption coefficient of 14,150 M−1 cm−1 at 412 nm [42]. HOSCN
(0-100 μM) was incubated with 0.5 mg mL−1 SR vesicles in 50 mM MOPS buffer, pH 7.0,
and 10 mM MgCl2 for 2 h at 21 °C. SR vesicles were also incubated with up to 300 μM
HOSCN that had been left to decompose overnight at 21 °C. HOCl was prepared by diluting
a concentrated stock solution of NaOCl in water. SR vesicles (0.5 mg mL−1) were incubated
with 0-100 μM HOCl in saline-sodium citrate (SSC) buffer, pH 7.0, and 10 mM MgCl2 for
1 h at 21 °C. For the time-dependent experiments, SR vesicles were treated with 50 μM
HOCl in the same manner for 1-60 min. Aliquots of control- and oxidant-treated SR were
subsequently taken for analysis. Oxidant-treated SR vesicles were further incubated with 2.5
mM dithiothreitol (DTT) for 30 min at 21°C to determine whether inhibition of Ca2+-
ATPase activity was reversible.
Incubation of SR vesicles with MPO-derived oxidants
SR vesicles (0.5 mg mL−1) were incubated with 100 nM MPO and 50 μM H2O2 for 1 h at
21 °C with either: 10 mM MgCl2 and 1× SSC buffer, pH 7.0 (to generate HOCl only); or 10
mM MgSO4, 50 μM NaSCN and 5 mM MOPS, pH 7.0 (to generate HOSCN only); or 10
mM MgCl2, 50 μM NaSCN and 1× SSC buffer, pH 7.0 (to generate both HOCl and
HOSCN). Negative controls omitting MPO, H2O2, NaSCN and Cl− individually were also
included.
Sarco/endo-plasmic reticulum Ca2+-ATPase (SERCA) activity assay
Total, Ca2+-dependent, and basal SERCA ATPase activity were determined by measurement
of inorganic phosphate (Pi) in the presence of the calcium ionophore, A23187. Reactions
contained 50 μg mL−1 SR in 25 mM MOPS, pH 7.0, 6 μM A23187, 5 mM MgCl2, and
either 1 mM EGTA or 0.1 mM CaCl2. Five mM ATP was added to start the reaction, and Pi
was measured colorimetrically as described previously [43], with 10 % (v/v) Tween-20
replacing Sterox. Phosphate standards were included to quantify the Pi content of SR
samples. In order to calculate Ca2+-dependent ATPase activity, the basal activity (assays
containing EGTA) was subtracted from the total activity (assays containing CaCl2). The
measured activity was attributed to SERCA as the Ca2+-ATPase activity was completely
inhibited by the addition of the SERCA-specific inhibitor, thapsigargin (20 μM) [44].
Quantification of thiols
Prior to thiol quantification, oxidant-treated SR samples were denatured by exposure to 10
μL 10 % (w/v) sodium dodecyl sulfate (SDS) in sodium phosphate buffer, pH 7.4, for 30
min at 37 °C. SR thiol groups were quantified by labeling Cys residues with the fluorescent
dye, ThioGlo (TG1), as described previously [45]. Briefly, a stock solution of 2.6 mM TG1
was prepared in acetonitrile. Immediately prior to the assay, a 1:100 dilution of the TG1
stock was made in PBS. Fifty μL control or oxidant-treated SR vesicles were added to wells
of a 96 well plate, followed by 50 μL diluted TG1. The plate was incubated for 5 min in the
dark at 21 °C, with the fluorescence then measured at λex 384 nm and λem 513 nm. Thiol
concentrations were calculated from a GSH standard curve.
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Quantification of chloramine formation
SR vesicles (0.5 mg mL−1) were incubated with 0-100 μM HOCl in SSC buffer, pH 7.0, and
10 mM MgCl2 for 15 min at 21 °C. The formation of HOCl-derived chloramines was
measured using the TNB assay as described previously [45]. Briefly, aliquots of control- and
oxidant-treated SR were reacted with TNB (5-thio-2-nitrobenzoic acid; prepared by alkaline
hydrolysis of DTNB with NaOH), and chloramine concentration determined by
measurement of absorbance at 412 nm using a molar absorption coefficient of 14,150 M−1
cm−1 [42].
Gel electrophoresis
The electrophoretic mobility of SR proteins following treatment with 0-100 μM HOCl or
HOSCN (incubated for 1 or 2 h, respectively) was determined using SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) under reducing conditions. Following exposure to oxidant
(as detailed above), SR samples were mixed with Tris-glycine-SDS running buffer and
loaded into Tris-glycine 4-15 % SDS-PAGE gradient gels. Gels were run at 150 V for 50
min and then stained using Coomassie Blue in isopropanol and glacial acetic acid.
Electrophoresis was also carried out to examine the loss of thiol groups from HOCl- and
HOSCN-treated SR in the presence of the thiol indicator, IAF, as described previously [45].
Briefly, 100 μM IAF in DMSO was added to control and oxidized SR samples and
electrophoresis carried out as described above. Gels were scanned for fluorescence with λex
384 nm and λem 513 nm, followed by Coomassie Blue staining to confirm molecular mass.
Cell Culture
Commercial stocks of HCAEC were thawed and transferred into T-75 flasks containing 10
mL MesoEndo Cell Growth Medium and incubated overnight at 37 °C in a 5 % O2/95 %
CO2 incubator. Medium was replaced following overnight culture, and every second day
thereafter. HCAEC reached 90 % confluency within approximately 7 days, at which time
HCAEC were subcultured. Existing medium was removed and HCAEC washed twice with
PBS before application of Trypsin/EDTA. HCAEC were incubated for 2-5 min at 37 °C in a
5 % O2/95 % CO2 incubator before the addition of 10 mL medium to inhibit tryptic activity.
HCAEC were then centrifuged at 525 g for 5 min, supernatant removed and pellet re-
suspended in 3-4 mL medium. One mL re-suspended HCAEC was transferred to T-75 flasks
containing 9 mL medium. Fura-2AM studies were performed on HCAEC 0-1 days
following subculture.
Measurement of intracellular calcium
Intracellular calcium was monitored using the fluorescent indicator Fura-2AM (1 μM, λex
340/380 nm, λem 510 nm) in a HEPES-buffered solution (HBS) containing (in mM): KCl
5.33, MgSO4 0.41, NaCl 139, Na2HPO4 5.63, glucose 5, HEPES 20, glutamine 2, and
Ca(NO3)2 2.5 (adjusted to pH 7.4 with NaOH), at 37 °C as described previously [46].
Fluorescence was measured using a Hamamatsu Orca ER digital camera attached to an
inverted Nikon TE2000-U microscope. Metamorph 6.3 was used to quantify the signal by
manually tracing cells. An equivalent region not containing cells was used as background
and was subtracted. Ratiometric 340/380 nm fluorescence was plotted relative to the pre-
treatment fluorescence assigned a value of 1.0. Fluorescent ratios recorded over 3 min were
averaged 7 min following addition of either HOCl alone, HOCl in the presence of 10 mM
NaSCN (thus generating HOSCN) [47], or 10 mM NaSCN alone, and reported as a
percentage from the baseline pre-treatment average. In some experiments cells were pre-
exposed to Ang II (1 nM) for 10 min and changes in Fura 2 fluorescence were recorded.
NaSCN (10 mM) was then added, followed by increasing concentrations of HOCl as
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described above. Cell death was assessed after addition of propidium iodide at the end of
each experiment.
Statistical analysis
Statistical analyses were carried out using GraphPad Prism 5 for Windows (GraphPad
Software, La Jolla, USA), with P < 0.05 considered significant. Details of specific tests
performed for each experiment are given in the Figure legends.
Results
HOSCN and HOCl inhibit SERCA Ca2+-ATPase activity
Fig. 1a shows SERCA Ca2+-ATPase activity following incubation of rat skeletal muscle SR
vesicles with 0-100 μM HOSCN for 2 h at 21 °C and pH 7.0, with and without subsequent
incubation with 2.5 mM DTT for 30 min. Freshly prepared HOSCN significantly inhibited
SERCA activity at all concentrations tested. Decomposed HOSCN at concentrations of up to
300 μM had no effect on SERCA activity (data not shown). Subsequent incubation of
HOSCN-treated SR with 2.5 mM DTT for 30 min at 21 °C resulted in higher levels of
SERCA activity compared to the non-DTT treated samples at 10 μM HOSCN, indicating
that the oxidant-induced loss in SERCA activity was partially reversible.
Analogous experiments with HOCl also resulted in a reduction in SERCA activity at all
concentrations tested (Fig. 1b). SERCA inactivation was also assessed using 50 μM HOCl
over a time course between 1 and 60 min. A significant reduction in SERCA activity was
observed at the first time point examined (1 min), and at all subsequent time points (data not
shown), indicating that HOCl rapidly inactivates this enzyme. Subsequent incubation of the
HOCl-treated SERCA with 2.5 mM DTT for 30 min at 21 °C before assessment of activity
indicated that SERCA activity was partially recovered with DTT treatment, when
concentrations of up to 50 μM HOCl were employed.
These data suggest that treatment of SERCA with low concentrations of oxidants (10 μM
HOSCN, up to 50 μM HOCl) results in a partially reversible loss of enzyme activity, with
this ascribed to the formation of reversible oxidation products, whereas high oxidant
concentrations resulted in irreversible modification of the protein.
Enzymatic MPO systems inhibit SERCA Ca2+-ATPase activity
The effect of oxidants generated by enzymatic MPO/H2O2/halide/pseudohalide ions systems
on SERCA activity was subsequently investigated (Fig. 2). Incubation of SR vesicles with
MPO, H2O2, and either SCN− or Cl− individually, or both SCN− and Cl−, caused a
significant inhibition of Ca2+-ATPase activity compared to native SERCA. Omission of
individual components (i.e. MPO, H2O2 or SCN−/Cl−) from the complete reaction mixture
did not result in any effect on SERCA activity.
HOCl and HOSCN alter the electrophoretic mobility of SERCA
SDS-PAGE separation of native and oxidant-treated SERCA preparations was carried out
using 4-15 % gradient gels with the protein bands visualized by Coomassie Blue staining.
Following exposure of SR to increasing concentrations of HOSCN, a concentration-
dependent loss of the band assigned to SERCA at ∼ 100 kDa [48] was observed, with a
concomitant increase in the presence of high-molecular-mass aggregates in the wells of the
gel (Fig. 3a). With HOCl, increasing concentrations of oxidant resulted in a partial loss of
the protein band assigned to SERCA. In addition, high-molecular-mass aggregates were
detected in the wells of the gel, but to a lesser extent than observed with HOSCN (Fig. 3b).
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SERCA thiol groups are oxidized on treatment with HOSCN and HOCl
The potential loss of Cys residues in SR vesicles on oxidant exposure was examined using
the ThioGlo assay. Incubation of SR with 0-100 μM HOSCN for 2 h at 21 °C and pH 7.0
followed by SDS denaturation for 30 min at 37 °C resulted in a significant loss of thiol
groups for ≥ 25 μM HOSCN, when compared to control samples (Fig. 4a). Similarly,
exposure of SR to 0-100 μM HOCl for 1 h at 21 °C and pH 7.0, with subsequent SDS
denaturation for 30 min at 37 °C, produced significant SR thiol loss at concentrations of 25
μM HOCl and above (Fig. 4b). For HOSCN, the loss of SR thiol groups occurred in a
concentration-dependent manner similar to the observed inhibition of Ca2+-ATPase activity,
suggesting HOSCN is targeting the key SERCA thiol groups critical for enzyme activity. In
contrast, the loss of free thiol groups in HOCl-treated SR vesicles was preceded by
significant inhibition of SERCA activity.
To determine whether Cys residues present on SERCA were being modified by HOSCN and
HOCl (as opposed to those on other proteins which might be present in the partially-purified
preparations), control and oxidized SERCA preparations were treated, post-oxidant
exposure, with the fluorescent thiol-derivatization agent, IAF (100 μM), and separated by
SDS-PAGE (see Materials and Methods). Incubation with 0-100 μM HOSCN for 2 h
resulted in a loss of the IAF-reactive groups present on the protein band assigned to SERCA,
indicating that HOSCN oxidizes SERCA Cys residues in a concentration-dependent manner.
Almost complete loss of the Cys residues was detected with HOSCN concentrations ≥ 50
μM (Fig. 4c). Similar experiments with SR and 0-100 μM HOCl for 1 h resulted in a partial
loss of SERCA thiol groups (Fig. 4d), which correlated with the loss of SR thiols quantified
by the ThioGlo assay. These results support the hypothesis that SERCA Cys residues are
oxidized by MPO-derived oxidants, with this occurring with greater selectivity with
HOSCN compared to HOCl.
HOCl-mediated formation of chloramines on SR vesicles
The potential oxidation of other targets on SR vesicles by HOCl was examined by assay of
chloramine (RNHCl formed by reaction of HOCl with amine groups) formation on SR
vesicles, by use of the TNB assay, following exposure to 0-100 μM HOCl. A dose-
dependent increase in chloramines was detected upon treatment of SR vesicles with HOCl,
which was statistically significant at 75 μM or higher HOCl concentrations (Fig. 5). At 100
μM HOCl, ∼13 μM chloramines were detected, suggesting that a significant proportion of
the HOCl is reacting with targets apart from Cys residues on the SR proteins. These data are
likely to underestimate attack by HOCl at non-Cys targets as reaction with methionine (Met)
and cystine residues cannot be quantified using this method, despite these being highly
reactive targets for this oxidant [22]. HOSCN does not react at a significant rate with these
other amino acids, and does not generate chloramines [24].
Exposure of HCAEC to HOCl and HOSCN increases intracellular Ca2+ in human coronary
artery endothelial cells (HCAEC)
In the light of the above data that indicate that the MPO enzymatic system and preformed
oxidants can oxidize Cys residues and attenuate SERCA activity, subsequent experiments
were carried out to determine whether similar oxidant exposure increased intracellular Ca2+
levels in HCAEC as a result of the potential inhibition of SERCA activity, a key Ca2+
sequestrating system in such cells.
Changes in Fura-2AM 340/380 nm ratiometric fluorescence in HCAEC, assigned to an
increased level of cytosolic Ca2+, were detected on exposure of the cells to increasing
concentrations of HOCl. Treatment with HOCl alone resulted in a concentration-dependent
increase in Fura-2AM fluorescence in the absence of cell death, as assessed by the
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subsequent addition of propidium iodide (Fig. 6a). Similar results were recorded in the
absence of extracellular Ca2+, suggesting the source of the higher cytosolic Ca2+
concentrations was intracellular (Fig. 6b). To further explore this, HCAEC were exposed to
4 μM nisoldipine, a blocker of L-type Ca2+ channels, or 4 μM Ru360, an inhibitor of
mitochondrial calcium uniporter. Neither nisoldipine nor Ru360 attenuated the increase in
Fura-2AM fluorescence after exposure to HOCl (Fig. 7a,b). However, exposure of HCAEC
to 3 μM thapsigargin, an agent that blocks Ca2+ re-uptake into internal stores (including via
SERCA), significantly attenuated the increase in Fura-2AM fluorescence in response to
HOCl (Fig. 7c). Similar results were recorded in the absence of extracellular Ca2+ (Fig. 7d).
The effect of HOSCN on intracellular Ca2+ was also examined. Treatment of HCAEC with
HOSCN resulted in a concentration-dependent increase in Fura-2AM fluorescence in the
absence of cell death (Fig. 8a). Exposure to nisoldipine or Ru360 did not alter the increase in
Fura-2AM fluorescence (Fig. 8b and c), however, thapsigargin significantly attenuated the
increase in Fura-2AM fluorescence in response to HOSCN (Fig. 8d). Pre-treatment of the
HCAEC with Ang II (1 nM), which activates the NADPH oxidase complex of endothelial
cells as well as multiple other pathways (e.g. [49]), significantly enhanced the increase in
intracellular Ca2+ induced by low levels of HOSCN (2 μM), but this stimulatory action was
lost at higher doses of HOSCN (Fig. 9).
Discussion
Substantial evidence links elevated levels of MPO, and the oxidants that it generates, with
multiple inflammatory diseases including atherosclerosis, neurodegenerative conditions,
arthritis, asthma, cystic fibrosis, kidney damage and some cancers (reviewed in [1-3]). This
association is believed to arise from the MPO-mediated generation of hypochlorous acid
(HOCl, from Cl−); hypobromous acid (HOBr, from Br−) and hypothiocyanous acid
(HOSCN, from SCN−) by H2O2, and subsequent reaction with cellular targets. The
proportion of each of these species is determined, at least in part, by the relative
concentrations of the parent halide/pseudohalide ions in biological fluids, with the yield of
HOSCN higher in subjects who smoke, or consume certain foodstuffs [29].
Previous studies have indicated that both HOCl and HOSCN rapidly oxidize thiol groups
present on both low-molecular-mass molecules (e.g. the key intracellular antioxidant and co-
factor, GSH) and on proteins (Cys residues), and that damage to proteins predominates over
other targets in most situations [23]. Whilst HOSCN has been shown to react in a selective
manner with thiol (RSH) [24,25,50] and selenol (RSeH) groups [25], HOCl reacts rapidly
with multiple other residues including disulphides (cystine), methionine (Met) and amine-
containing (lysine and histidine) residues [21,22].
Maintenance of intracellular Ca2+ levels is critical to cell function and survival, with failure
to maintain Ca2+ concentrations within particular limits associated with aberrant cell
signaling, cellular dysfunction and apoptosis/necrosis [51,52]. SERCA plays a critical role
in regulating Ca2+ homeostasis, by sequestering cytosolic Ca2+ released from cellular
organelles (e.g. mitochondria or the endoplasmic reticulum), or entering the cell from
external pools. This enzyme pumps Ca2+ into the sarco/endoplasmic reticulum at the
expense of ATP, thus lowering intracellular Ca2+ levels. Through this process of Ca2+
sequestration, SERCA mediates smooth, cardiac and skeletal muscle cell relaxation, and
also participates in a variety of cellular functions relevant to growth, proliferation and
apoptosis [30,31]. Previous studies have shown that SERCA activity can be modulated by
the reversible oxidation of specific Cys residues (e.g. NO. -dependent S-glutathionylation)
[33]; this is impaired in ageing tissues [34] and cardiovascular disease [33]. When reactive
species are generated at higher levels, SERCA Cys residues can become irreversibly
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oxidized, with a consequent loss of function [35]. Putative biological oxidants such as
peroxynitrite [36], NO.-derived species [37] and amino acid peroxides [38] have been shown
to induce irreversible inactivation by selective targeting of critical Cys residues on SERCA.
In the current study, both pre-formed HOCl and HOSCN (at pathophysiologically-relevant
concentrations) and an active MPO enzyme system have been shown to inhibit the Ca2+-
ATPase activity of semi-purified SERCA. This loss of activity could be partially restored by
subsequent incubation of the oxidant-treated samples with DTT, consistent with reversible
oxidation of at least some of the affected targets. Significant loss of activity occurred even at
relatively low (10 μM) concentrations of HOCl and HOSCN, while decomposed HOSCN
did not induce any significant loss of activity. Furthermore, a fast reaction rate of HOCl was
observed, with no time-dependent changes in activity detected after 60 s of incubation with
the oxidant. The rapid inhibition of activity with HOCl is consistent with previous rate
constant data for the reactions of this species [21,22]. Examination of analogous samples
using SDS-PAGE resulted in a marked loss in staining of the protein band assigned to
SERCA with increasing HOSCN concentrations, but much less marked loss in the case of
HOCl. In the former case, the loss of parent protein was associated with an increased level
of high-molecular-mass materials that remained in the protein wells; this is consistent with
the presence of very large oxidant-induced aggregates. No additional discrete bands were
detected with either oxidant, suggesting that fragmentation or specific dimer formation is not
occurring to a significant extent. The less dramatic changes observed with HOCl are
consistent with reaction of this oxidant at other sites (cf. the chloramine data) as well as with
critical Cys residues; this conclusion is supported by the less pronounced loss of Cys
residues detected in the thiol tagging experiments using IAF (cf. Fig. 4).
The effect of HOCl on SERCA activity has been investigated previously and it has been
concluded that this oxidant can modulate SERCA activity [53-56]. However, the buffers
used in these studies (e.g. HEPES) contained amine groups, which react readily with HOCl
to form chloramines [21], particularly at the high concentrations of HOCl used (up to 3 mM)
relative to the SERCA protein concentration (0.1 − 1 mg mL−1). The presence of this
alternative target for the oxidant, and potential secondary reactions of the chloramines
(which retain some of the oxidizing power of HOCl [57]) complicates the analysis of this
previous data and may account for the discrepancies between these sets of data. In the
present study, saline-sodium citrate buffer, pH 7.0, which does not contain any amine
groups, was employed to avoid such confounding factors, thereby enabling the effects of
HOCl per se to be examined.
Inhibition of SERCA activity was also detected with a complete MPO/H2O2/halide/
pseudohalide system. SERCA activity was impaired by 50% with the MPO/H2O2/Cl−
system relative to untreated samples, and 65% with a MPO/H2O2/SCN− system. The
presence of both Cl− and SCN− in the enzyme system also resulted in marked activity loss.
In contrast, the absence of these ions (i.e. treatment with MPO/H2O2 alone) did not result in
a significant loss of enzyme activity, eliminating MPO peroxidase activity (i.e. one-electron
oxidation reactions; see [2]) as a source of this damage.
The potential role of oxidation of thiol groups (i.e. Cys residues) on SERCA in the observed
loss of activity was examined by quantification of total reduced thiols in the preparations,
and by specific IAF labeling of reduced thiols on the protein band ascribed to SERCA on
protein gels. As a result of oxidant exposure, the total levels of thiols in the preparations
(which may include some contributions from other proteins also present in the isolated SR,
evident as weak additional protein bands in Fig. 3), decreased in a concentration-dependent
manner. The extent of thiol loss at low oxidant concentrations was more marked with
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HOSCN than HOCl; this is in accord with recent studies on the selectivity of HOSCN for
thiols [24,29], and the reaction of HOCl at other sites, as discussed above.
The present study subsequently examined whether these MPO-derived oxidants can perturb
Ca2+ homeostasis in HCAEC through a SERCA-dependent mechanism. Such modifications
may generate or exacerbate endothelial dysfunction, a key early event in atherosclerosis.
Exposure of isolated cells, with or without external Ca2+, to either HOSCN or HOCl
resulted in concentration-dependent increase in intracellular Ca2+ levels under conditions
that did not result in an immediate loss of cell viability. The magnitude of the elevation in
Ca2+ levels was dependent on the oxidant employed, with HOSCN (generated by reaction of
HOCl with excess SCN− [47]) giving rise to a greater increase than the corresponding
concentration of HOCl. SCN− alone had no effect on intracellular Ca2+ levels.
Preliminary studies employing acute Ang II pre-treatment, which would be expected to
enhance NADPH oxidase activity and thereby increase O2−• and H2O2 levels [49], enhanced
the rise in intracellular Ca2+ induced by low (but not high) levels of HOSCN. This
additional rise is tentatively ascribed to the additional effects of O2−• and H2O2 on
intracellular targets; whether this results in additional SERCA inhibition (e.g. induced by
H2O2) or via effects on other processes (e.g. kinase and phosphatase activity, effects on cell
signaling) remains to be determined.
The absence of extracellular Ca2+ did not result in any significant differences in the nature
or the extent of cytosolic Ca2+ accumulation, indicating that an influx of extracellular Ca2+
is not responsible for the observed effects. Similarly, the presence of either nisoldipine (a
blocker of L-type Ca2+ channels) or Ru360 (an inhibitor of mitochondrial calcium uniporter)
had no significant effect on the intracellular Ca2+ increases, consistent with neither influx of
Ca2+ via L-type channels, or Ca2+ release from mitochondria being major pathways. In
contrast, thapsigargin, a non-competitive inhibitor of SERCA, completely attenuated the
Ca2+ accumulation induced by both HOCl and HOSCN. As thapsigargin is a re-uptake
inhibitor of cytosolic Ca2+ in the sarco/endoplasmic reticulum, rather than a release
inhibitor, these data suggest that Ca2+ release from one or more (unidentified) intracellular
stores must be occurring, and that the effect of the oxidants is on the removal of
accumulated cytosolic Ca2+; this is consistent with the loss of SERCA activity seen in the
experiments with semi-purified SERCA. The source of the cytosolic Ca2+ has not been
identified, and is the subject of on-going studies, though it should be noted that previous
studies have provided evidence for oxidant-mediated (H2O2 and HOCl) release of Ca2+ from
internal stores [53,54].
Previous studies have demonstrated that the accumulation of cytosolic Ca2+ has multiple
downstream consequences, including the perturbation of critical cellular signaling pathways,
modulation of the activity of key enzymes, and when the extent of Ca2+ accumulation is
large, the induction of apoptosis [51,52]. It has also been reported that exposure of cells to
HOSCN and HOCl can induce both apoptosis and necrosis, and that apoptosis is a key
process with HOSCN, at least with some cell types [27]. The data reported here may provide
a rationale for these observations, though this may be cell-type dependent [58]. Furthermore,
as many enzymes are Ca2+-dependent, the perturbations in Ca2+ levels induced by these
oxidants may contribute to wider cellular dysfunction, a key and early process in many
inflammatory diseases, including atherosclerosis [59].
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HCAEC human coronary artery endothelial cells
HOCl the mixture of hypochlorous acid and its anion present at pH 7.4




SERCA sarco/endoplasmic reticulum Ca2+-ATPase
SCN− thiocyanate ions
SR sarco/endoplasmic reticulum
SSC buffer saline-sodium citrate buffer
TNB 5-thio-2-nitrobenzoic acid
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HOSCN and HOCl inhibit the Ca2+-ATPase activity in SR vesicles. (a) Ca2+-ATPase
activity, attributed to SERCA, was measured after exposure to 0-100 μM freshly prepared
HOSCN for 2 h (solid-filled bars), with subsequent exposure to 2.5 mM dithiothreitol (DTT)
for 30 min (hatched bars) at 21 °C and pH 7.0. (b) As (a) except treatment with 0-100 μM
HOCl for 1 h (solid-filled bars), and subsequent exposure to DTT (hatched bars). For both
(a) and (b), data are expressed as mean + SEM of SERCA activity compared to native SR
vesicles (0 μM HOCl). Letters depict statistically significant differences in activity between
oxidant-treated and control vesicles by one-way ANOVA with Dunnett's post-hoc tests (a, P
< 0.01; b, P < 0.001). Two-way ANOVA was carried out with Bonferroni post-hoc tests to
compare data at each oxidant concentration; asterisks depict statistically significant
differences between the absence and presence of DTT treatment.
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Oxidants generated by MPO inhibit SR Ca2+-ATPase activity. SR Ca2+-ATPase activity as
measured after incubation with complete or incomplete MPO systems for 1 h at 21 °C and
pH 7.0. The complete MPO system consisted of: 0.5 mg mL−1 SR, 100 nM MPO and 50
μM H2O2 plus either: 10 mM MgCl2 and 1× SSC buffer, pH 7.0 (to generate HOCl only);
or 10 mM MgSO4, 50 μM NaSCN and 5 mM MOPS, pH 7.0 (to generate HOSCN only); or
10 mM MgCl2, 50 μM NaSCN and 1× SSC buffer, pH 7.0 (to generate both HOCl and
HOSCN). Control samples containing no MPO, no H2O2, no NaSCN and no Cl−
individually, were also examined. Data are expressed as mean + SEM of SERCA activity
compared to native SR vesicles, with statistical analysis carried out using one-way ANOVA
with Dunnett's post-hoc tests.
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Exposure of SR vesicles to HOSCN and HOCl alters the electrophoretic mobility of SERCA
protein as assessed by SDS-PAGE separation of native and oxidant-treated SR vesicles with
subsequent Coomassie Blue staining. (a) Treatment of SR with 0-100 μM freshly prepared
HOSCN resulted in a concentration-dependent loss of the SERCA band, and an increase in
high molecular mass aggregates in the wells of the gel. Lane 1: Molecular mass markers;
lane 2: negative control; lane 3: Native SR (0 μM HOSCN); Lanes 4-8: SR treated with 10,
25, 50, 75 and 100 μM HOSCN, respectively. (b) As (a) except with HOCl. Lane 1: native
SR (0 μM HOCl); lanes 2-6: SR treated with 10, 25, 50, 75 and 100 μM HOCl, respectively.
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Exposure of SR preparations to HOSCN and HOCl results in oxidation of thiol groups as
assessed using the ThioGlo assay. (a) SR were treated with 0-100 μM HOSCN for 2 h at 21
°C and pH 7.0, followed by SDS denaturation for 30 min at 37 °C. Black bars indicate
concentration of free thiol groups, and hatched bars the corresponding Ca2+-ATPase
activity. (b) As (a) except with 0-100 μM HOCl for 1 h. Bars depict mean + SEM of thiol
groups or SERCA activity. In both (a) and (b) oxidant-induced thiol loss relative control SR
was assessed by one-way ANOVA with Dunnett's post-hoc tests, with letters depicting
statistically significant difference versus the untreated control (a, P < 0.05; b, P < 0.01; c, P
< 0.001). Two-way ANOVA with Bonferroni post-hoc tests was used to compare thiol loss
and SERCA activity data at each oxidant concentration: asterisks denote statistically-
significant differences between these two parameters at the P < 0.05 level. (c) and (d), SDS-
PAGE separation of native and oxidant-treated SR labeled with the fluorescent thiol tag,
IAF; (c) treatment with HOSCN, (d) treatment with HOCl. For both gels: lane 1 is a
negative control; lane 2, native SR (0 μM oxidant); lanes 3-7: SR treated with 10, 25, 50, 75
and 100 μM oxidant, respectively. The band at ∼ 100 kDa is assigned to SERCA.
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Quantification of chloramine formation on SR vesicle proteins on exposure to HOCl. SR
vesicles were exposed to 0-100 μM HOCl for 15 min at 21 °C and pH 7.0, and chloramines
subsequently quantified by reaction with TNB at 412 nm. Bars depict mean + SEM of
chloramine concentration, with statistical analysis carried out using one-way ANOVA with
Dunnett's post-hoc tests compared to native SR.
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Exposure of human coronary artery endothelial cells (HCAEC) to HOCl increases
intracellular calcium levels as detected by Fura-2AM fluorescence. (A) Left panel:
Fura-2AM 340/380 nm fluorescence (340/380 fluorescence) recorded from HCAEC before
and after exposure to increasing concentrations of HOCl (open circles), and untreated
(control) HCAEC (filled circles). Arrows indicate sequential HOCl additions at the indicated
concentrations. Right panel: quantification of the changes from multiple cells with
increasing HOCl concentrations with data expressed as mean + SEM of % changes in
340/380 fluorescence. Numbers above bars represent n (cell number). (B) As (A), except
with cells present in Ca2+-free media.
Cook et al. Page 20














Internal calcium stores contribute to the increase in intracellular calcium observed in
HCAEC after exposure to HOCl. (A) Left panel: Fura-2AM 340/380 nm fluorescence
recorded from HCAEC before and after exposure to increasing concentrations of HOCl
(open circles) followed by 4 μM nisoldipine (Nisol) as indicated, and untreated (control)
HCAEC (filled circles). Arrows indicate time points of sequential HOCl additions at the
stated concentrations and addition of Nisol. Right panel: quantification of the changes from
multiple cells with increasing HOCl concentrations (black bars) and nisoldipine (horizontal
striped bar). Numbers above bars represent n (cell number). (B) As (A) except with HOCl
and 4 μM Ru360 (horizontal striped bar); * P < 0.05. (C) Fura-2AM 340/380 nm
fluorescence recorded from HCAEC before and after exposure to increasing concentrations
of HOCl (open circles), increasing concentrations of HOCl after pretreatment with 3 μM
thapsigargin for 10 min (cross symbols), and untreated (control) HCAEC (filled circles).
Dashed lines indicate time points of sequential HOCl additions at the stated concentrations.
Right panel: quantification of changes with increasing concentrations of HOCl. Black bars,
untreated cells (n = 8); diagonally hatched bars, HOCl treated cells (n = 14); grey bars,
thapsigargin-treated cells in absence of HOCl (n = 4); white bars, thapsigargin-treated cells
in presence of HOCl (n = 12). (D) As panel (C), except cells were present in media that did
not contain Ca2+. Black bars, untreated cells (n = 6); diagonally hatched bars, HOCl-treated
cells (n = 6); grey bars, thapsigargin-treated cells in absence of HOCl (n = 8); white bars,
thapsigargin-treated cells in presence of HOCl (n = 16). Data in right panels are expressed as
mean + SEM of % changes in 340/380 fluorescence.
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Exposure of HCAEC to HOSCN increases intracellular calcium. (A) Left panel: Fura-2AM
340/380 nm fluorescence (340/380 fluorescence) recorded from HCAEC before and after
exposure to increasing concentrations of HOCl in the presence of 10 mM NaSCN to
generate HOSCN (open circles), and HCAEC exposed to 10 mM NaSCN only (filled
circles). Arrows indicate time points of sequential HOCl treatments at the stated
concentrations. Right panel: quantification of the changes from multiple cells exposed to
increasing concentrations of HOSCN. Black bars, cells exposed to 10 mM NaSCN only (n =
16); white bars, cells exposed to HOSCN generated from HOCl in the presence of 10 mM
NaSCN (n = 16). (B) Left panel: as (A) except with 4 μM nisoldipine (Nisol) in the presence
of 10 mM NaSCN, with arrows indicating time points of HOSCN treatment and Nisol
addition. Right panel: quantification of the changes from multiple cells exposed to
increasing concentrations of HOSCN and nisoldopine (horizontal striped bar). Numbers
above bars represent n (cell number). (C) As (A) and (B), except with 4 μM Ru360
(horizontal striped bar). (D) Fura-2AM 340/380 nm fluorescence recorded from HCAEC
before and after exposure to increasing concentrations of HOSCN (open circles, generated
from 10 mM NaSCN plus HOCl), increasing concentrations of HOSCN (cross symbols)
after pretreatment with 3 μM thapsigargin for 10 min, and HCAEC treated with 10 mM
NaSCN alone (filled circles). Dashed lines indicate time points of sequential HOSCN
additions at the stated concentrations. Right panel: quantification of changes with increasing
concentrations of HOSCN. Black bars, cells exposed to 10 mM NaSCN alone (n = 16);
diagonally hatched bars, cells exposed to HOSCN generated from HOCl in the presence of
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10 mM NaSCN (n = 16); white bars, cells pre-treated with 3 μM thapsigargin for 10 min
exposed to HOSCN generated from HOCl in the presence of 10 mM NaSCN (n = 12). Data
in all right panels are expressed as mean + SEM of % changes in 340/380 fluorescence.
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Effect of Ang II on HOSCN mediated changes in intracellular calcium. Fura 2 fluorescence
was recorded in cells before and after exposure to Ang II (1 nM) for 10 min to determine
baseline changes induced by Ang II. HCAECs were then treated with increasing
concentrations of HOSCN. Dashed bars are treatment with Ang II alone (bar labeled AngII)
or Ang II plus the stated concentration of HOSCN. Black bars are control cells (no Ang II)
treated with the stated levels of HOSCN. The number of experiments are indicated above
each bar. * indicates P < 0.05 for the Ang II pre-treatment with HOSCN, versus HOSCN
alone.
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